CPSC Proposes to Exempt Powder Forms of 2 Drugs from Child-Resistant Packaging
The Consumer Product Safety Commission has issued a proposed rule to amend its child-resistant packaging requirements to exempt powder formulations of two oral prescription drugs, colesevelam hydrochloride (for adults with type 2 diabetes mellitus) and sevelamer carbonate (for chronic kidney…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
disease patients on dialysis), on the basis that child-resistant packaging is not needed to protect young children from serious injury or illness. Comments are due by May 2, 2011.